Imunon, Inc. Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent
Imunon, Inc. (IMNN) reported Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent of 3.00% for the 123-month period ending 2018-12-31, per its 10-K filed 2015-03-12.
Discontinued › Notes › Compensation Related Costs › Retirement Benefits › Defined Contribution Plan
us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent · last filed 2018-03-27
- Imunon, Inc. defined contribution plan, maximum annual contributions per employee, percent for the quarter ending 2008-12-31 was 3.00%.
- Imunon, Inc. defined contribution plan, maximum annual contributions per employee, percent for fiscal 2017 was 3.00%, a 0.00% change from fiscal 2016.
- Imunon, Inc. defined contribution plan, maximum annual contributions per employee, percent for fiscal 2016 was 3.00%.
| Period end | Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent 3 month | Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent 12 month | Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent 63 month | Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent 123 month |
|---|---|---|---|---|
| 2018-12-31 | 3.00% 10-K · filed 2015-03-12 | |||
| 2017-12-31 | 3.00% 10-K · filed 2018-03-27 | |||
| 2016-12-31 | 3.00% 10-K · filed 2017-03-24 | |||
| 2013-12-31 | 3.00% 10-K · filed 2014-03-13 | |||
| 2008-12-31 | 3.00% 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |